fulvestrant accord fulvestrant 250 mg/5 ml solution for injection pre-filled syringe
accord healthcare pty ltd - fulvestrant, quantity: 250 mg - injection, solution - excipient ingredients: benzyl alcohol; castor oil; benzyl benzoate; ethanol - fulvestrant accord is indicated for the treatment of postmenopausal women with: ? hormone-receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, locally advanced or metastatic breast cancer who have not been previously treated with endocrine therapy. ? hr positive, locally advanced or metastatic breast cancer who have progressive disease following prior endocrine (anti-oestrogen or aromatase inhibitor) therapy.
dexmedetomidine accord dexmedetomidine (as hydrochloride) 200 micrograms/2 ml injection vial
accord healthcare pty ltd - dexmedetomidine hydrochloride, quantity: 118 microgram/ml (equivalent: dexmedetomidine, qty microgram/ml) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - icu sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of dexmedetomidine accord by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.
ketraccord
accord healthcare pty ltd - levetiracetam -
levitaccord tablets
accord healthcare pty ltd - levetiracetam -
olanzaccord tablets
accord healthcare pty ltd - olanzapine -
sildaccord pht tablets 20 mg
accord healthcare pty ltd - sildenafil citrate -
sildaccord tablets
accord healthcare pty ltd - sildenafil citrate; sildenafil -
temaccord
accord healthcare pty ltd - temozolomide -
quetiaccord tablets
accord healthcare pty ltd - quetiapine fumarate -
accord doxorubicin
accord healthcare pty ltd - doxorubicin hydrochloride -